marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-28-2024
Ekso Bionics Holdings Balance Sheet 2011-2024 | EKSO
Annual Balance Sheet Ekso Bionics Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-7.55 M | -19.1 M | - | -7.45 M | -8.13 M | -2.67 M | -20.8 M | -10 M | -19.5 M | -25.1 M | -19.9 K | -4.84 K | - |
Long Term Debt |
723 K | 1.09 M | - | 3.08 M | 407 K | 2.65 M | 4.83 M | 6.79 M | - | 77 K | - | - | - |
Long Term Debt Current |
363 K | 341 K | 229 K | 548 K | 421 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 11.2 M | 7.29 M | 4.8 M | 7.43 M | 11.6 M | 14.8 M | 4.06 M | - | - | - |
Total Current Liabilities |
8.12 M | 9.2 M | 6.86 M | 4.97 M | 7.83 M | 10.1 M | 9.16 M | 6.31 M | 8.62 M | 6.61 M | - | - | - |
Total Liabilities |
16.3 M | 15.5 M | 11.9 M | 16.2 M | 15.1 M | 14.9 M | 16.6 M | 17.9 M | 23.4 M | 10.7 M | 14.1 K | 8.1 K | - |
Deferred Revenue |
1.99 M | 1.12 M | 1.22 M | 1.5 M | 1.49 M | 1.1 M | 1.1 M | 825 K | 3.96 M | 3.41 M | - | - | - |
Retained Earnings |
-239 M | -224 M | -209 M | -199 M | -183 M | -171 M | -144 M | -115 M | -91.4 M | -71.8 M | -16.9 K | -4.66 K | - |
Total Assets |
28.9 M | 40.9 M | 49.2 M | 20.6 M | 21.9 M | 17.7 M | 38 M | 24.4 M | 32.2 M | 33.5 M | 29.2 K | 8.44 K | - |
Cash and Cash Equivalents |
8.64 M | 20.5 M | 40.4 M | 12.9 M | 10.9 M | 7.66 M | 27.8 M | 16.8 M | 19.6 M | 25.2 M | 805 K | 1.74 M | - |
Book Value |
12.6 M | 25.4 M | 37.2 M | 4.43 M | 6.8 M | 2.73 M | 21.4 M | 6.53 M | 8.81 M | 22.8 M | 15.1 K | 343 | - |
Total Shareholders Equity |
12.6 M | 25.4 M | 37.2 M | 4.43 M | 6.8 M | 2.73 M | 21.4 M | 6.53 M | 8.81 M | 22.8 M | -36.4 M | -25.1 M | - |
All numbers in USD currency
Quarterly Balance Sheet Ekso Bionics Holdings
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
556 K | 659 K | 626 K | 723 K | 817 K | 907 K | 999 K | 1.09 M | - | - | 1.99 M | 1.99 M | 1.99 M | 1.99 M | 1.99 M | 1.99 M | 1.99 M | 1.99 M | 2.17 M | 407 K | 972 K | 1.54 M | 2.09 M | 2.65 M | 3.2 M | 3.75 M | 4.29 M | 4.83 M | 5.37 M | 5.91 M | 6.64 M | 6.79 M | 179 K | 202 K | 224 K | 246 K | 268 K | 103 K | 116 K | 129 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
14.3 M | 14.9 M | 14.9 M | 16.3 M | 15.9 M | 16.2 M | 15.8 M | 15.5 M | 10.7 M | - | 10.8 M | 11.9 M | 11.7 M | 12.9 M | 15.5 M | 16.2 M | 16.2 M | 16.2 M | 16.2 M | 15.1 M | 15.1 M | 15.1 M | 15.1 M | 14.9 M | 14.9 M | 14.9 M | 14.9 M | 16.6 M | 16.6 M | 16.6 M | 16.6 M | 17.9 M | 17.9 M | 17.9 M | 17.9 M | 23.4 M | 23.4 M | 23.4 M | 23.4 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 15.6 M | 15.6 M | 15.6 M | 15.6 M | 18.5 K | 18.5 K | 9.78 K | 8.1 K | - | - | - | - |
Deferred Revenue |
2.04 M | 1.93 M | 2.03 M | 1.99 M | 1.64 M | 1.29 M | 1.3 M | 1.12 M | 1.06 M | - | 1.12 M | 1.22 M | 1.29 M | 1.42 M | 1.49 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.49 M | 1.49 M | 1.37 M | 1.21 M | 1.1 M | 945 K | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 825 K | 825 K | 825 K | 825 K | 3.96 M | 3.96 M | 3.96 M | 3.96 M | 3.41 M | 3.41 M | 3.41 M | 3.41 M | 2.42 M | 2.42 M | 2.42 M | 2.42 M | - | - | - | - | - | - | - | - |
Retained Earnings |
-247 M | -245 M | -243 M | -239 M | -236 M | -233 M | -228 M | -224 M | -221 M | - | -213 M | -209 M | -206 M | -204 M | -203 M | -199 M | -199 M | -199 M | -199 M | -183 M | -183 M | -183 M | -183 M | -171 M | -171 M | -171 M | -171 M | -144 M | -144 M | -144 M | -144 M | -115 M | -115 M | -115 M | -115 M | -91.4 M | -91.4 M | -91.4 M | -91.4 M | -71.8 M | -71.8 M | -71.8 M | -71.8 M | -38 M | -38 M | -38 M | -38 M | - | - | - | -4.66 K | - | - | - | - |
Total Assets |
29.2 M | 27 M | 29 M | 28.9 M | 31.2 M | 34 M | 37.1 M | 40.9 M | 39.3 M | - | 44.2 M | 49.2 M | 50.7 M | 53 M | 56.5 M | 20.6 M | 20.6 M | 20.6 M | 20.6 M | 21.9 M | 21.9 M | 21.9 M | 21.9 M | 17.7 M | 17.7 M | 17.7 M | 17.7 M | 38 M | 38 M | 38 M | 38 M | 24.4 M | 24.4 M | 24.4 M | 24.4 M | 32.2 M | 32.2 M | 32.2 M | 32.2 M | 33.5 M | 33.5 M | 33.5 M | 33.5 M | 6.58 M | 6.58 M | 6.58 M | 6.58 M | 30 K | 12.7 K | 5.23 K | 8.44 K | - | - | - | - |
Cash and Cash Equivalents |
8.29 M | 5.88 M | 8.8 M | 8.64 M | 9.94 M | 13.3 M | 16.3 M | 20.5 M | 29.2 M | - | 36.2 M | 40.4 M | 43.4 M | 45.9 M | 49.5 M | 12.9 M | 12.9 M | 12.9 M | 12.9 M | 10.9 M | 10.9 M | 10.9 M | 10.9 M | 7.66 M | 7.66 M | 7.66 M | 7.66 M | 27.8 M | 27.8 M | 27.8 M | 27.8 M | 16.8 M | 16.8 M | 16.8 M | 16.8 M | 19.6 M | 19.6 M | 19.6 M | 19.6 M | 25.2 M | 25.2 M | 25.2 M | 25.2 M | 805 K | 805 K | 805 K | 805 K | 1.74 M | 30 K | 12.7 K | 8.44 K | 558 K | - | - | - |
Book Value |
14.9 M | 12.1 M | 14.1 M | 12.6 M | 15.3 M | 17.8 M | 21.3 M | 25.4 M | 28.6 M | - | 33.5 M | 37.2 M | 39.1 M | 40.1 M | 41 M | 4.43 M | 4.43 M | 4.43 M | 4.43 M | 6.8 M | 6.8 M | 6.8 M | 6.8 M | 2.73 M | 2.73 M | 2.73 M | 2.73 M | 21.4 M | 21.4 M | 21.4 M | 21.4 M | 6.53 M | 6.53 M | 6.53 M | 6.53 M | 8.81 M | 8.81 M | 8.81 M | 8.81 M | 22.8 M | 22.8 M | 22.8 M | 22.8 M | -9.05 M | -9.05 M | -9.05 M | -9.05 M | 11.4 K | -5.8 K | -4.55 K | 343 | - | - | - | - |
Total Shareholders Equity |
14.9 M | 12.1 M | 14.1 M | 12.6 M | 15.3 M | 17.8 M | 21.3 M | 25.4 M | 28.6 M | 31.7 M | 33.5 M | 37.2 M | 39.1 M | 40.1 M | 41 M | 4.43 M | 4.43 M | 4.43 M | 4.43 M | 6.8 M | 6.8 M | 6.8 M | 6.8 M | 2.73 M | 2.73 M | 2.73 M | 2.73 M | 21.4 M | 21.4 M | 21.4 M | 21.4 M | 6.53 M | 6.53 M | 6.53 M | 6.53 M | 8.81 M | 8.81 M | 8.81 M | 8.81 M | 22.8 M | 22.8 M | 22.8 M | 22.8 M | -36.4 M | -36.4 M | -36.4 M | -36.4 M | -25.1 M | - | -4.55 K | 343 | -10.4 M | - | - | - |
All numbers in USD currency